Julie B Schnur, PhD
img_Julie B Schnur
ASSOCIATE CLINICAL PROFESSOR | Population Health Science and Policy
Are you a patient?
Research Topics
Behavioral Health, Breast Cancer, Cancer, Complimentary/Alternative/Integrative Medicine, Education, Pain
Cancer-related quality of life, Psychosocial issues in cancer, healthcare retraumatization
As a clinical psychologist, my primary research aims are to: understand patients’ cognitive, emotional, behavioral, and physical reactions to cancer and its treatment; to understand how psychological factors contribute to patients’ symptoms, side-effects, treatment experiences, and adherence; to develop and test psychotherapeutic and mind-body interventions to help cancer patients manage symptoms, side-effects, and emotional distress at across all phases of the cancer continuum – from diagnosis through metastatic disease; and to train students and providers in sensitive practice and evidence-based approaches to improve cancer care. My current research foci are how a history of sexual abuse influences patients’ reactions to cancer and its treatment; how hypnosis can reduce pain in breast cancer survivors taking aromatase inhibitors; how to help radiation therapists elicit patients’ treatment preferences (and reduce triggering) in the breast radiotherapy setting; and training psychosocial cancer care providers in evidence-based psychotherapeutic techniques (e.g., hypnosis and rational-emotive behavior therapy to manage cancer-related fatigue). Over the years, much of my work has centered on improving quality of life in women undergoing breast cancer treatment. I am particularly interested in the use of qualitative research approaches to understand patients’ lived experiences of cancer and its treatment.

The Integrative Behavioral Medicine Program

BA, University of Pennsylvania

MA, St. John's University

PhD, St John's University

Postdoctoral Fellowship, Mount Sinai School of Medicine, Oncological Sciences

Internship, Clinical Psychology, Nassau University Medical Center


Mid-Career Investigator Award

Society of Behavioral Medicine


Hypnosis to reduce aromatase inhibitor (AI)-associated musculoskeletal pain and to improve AI adherence: An RCT to explore clinical efficacy and cost effects.



Training Providers in CBT plus Hypnosis - An Evidence-based fatigue intervention



Cancer treatment retraumatization in sexual abuse survivors



Dr. Harold and Golden Lamport Research Award

Icahn School of Medicine at Mount Sinai


Early Career Contribution Award

St. John’s University


E-counseling in Psychosocial Cancer Care: A Competency-Based E-learning Approach



Roy M. Dorcus Award for Best Clinical Paper

The Society for Clinical and Experimental Hypnosis


Presidential Commendation

The Society of Psychological Hypnosis

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Schnur did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.